Biotech | March 23, 2022
GMP certification for Exothera further extends its viral vector manufacturing capacity
The expansion makes Exothera one of the largest viral vector facilities in Europe
The expansion makes Exothera one of the largest viral vector facilities in Europe
New data, including two late-breaking clinical trial presentations on mavacamten and a new analysis of the GUARD-AF study, reinforce the company’s continued commitment to those living with cardiovascular disease
Twelve abstracts and two late-breaking presentations demonstrate AbbVie and Allergan Aesthetics' shared commitment to advancing research across a spectrum of dermatologic conditions and aesthetic indications
Milltrust Ventures will also assist Oncoshot with its expansion in Australia and India, where the latter has already established partnerships amongst apex cancer institutes
She joined Trivitron Healthcare in 1999 and has held several positions in the organisation
Enables millions of Indians to monitor their vitals without the need of any additional device
Expanded capabilities across pharma services network accelerate innovation and enhance productivity for customers
Blood contains a mixture of exosomes secreted from nearly all tissues and cells, and exosomes from other tissues can mask changes caused by disease, making it difficult to detect the presence of biomarkers that reflect disease
Data published in the prestigious journal ACS Central Science of the American Chemical Society
Hester's initial pet care portfolio will include products ranging from dermatology, grooming, anti-infective, and speciality products
Subscribe To Our Newsletter & Stay Updated
